Author: | Noy, A. |
Article Title: | HIV multicentric Castleman: Rituximab sans maintenance |
Abstract: | Whether maintenance therapy adds value in the treatment of HIV-associated multicentric Castleman disease (HIV1MCD) is unknown. In this issue of Blood, Dalla Pria et al have analyzed a prospective cohort to advocate that it is not.1 © 2017 by The American Society of Hematology. |
Journal Title: | Blood |
Volume: | 129 |
Issue: | 15 |
ISSN: | 0006-4971 |
Publisher: | American Society of Hematology |
Date Published: | 2017-04-13 |
Start Page: | 2045 |
End Page: | 2046 |
Language: | English |
DOI: | 10.1182/blood-2017-03-767558 |
PROVIDER: | scopus |
PUBMED: | 28408420 |
DOI/URL: | |
Notes: | Note -- Export Date: 2 October 2017 -- Source: Scopus |